Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Carglumic Acid

Carglumic Acid
Carglumic Acid (Ureidoglutaric acid) is an orphan drug used to treat hyperammonemia in patients with N-acetyl glutamate synthase absence. This rare hereditary disease results in elevated blood levels of ammonia, which can eventually cross the blood-brain barrier and lead to neurologic problems, coma, cerebral edema, and death. Carglumic acid was approved by the U.S. FDA on 18 March 2010.
Catalog No. T0755Cas No. 1188-38-1
Select Batch
Purity:99.8%
Contact us for more batch information

Resource Download

Carglumic Acid

Purity: 99.8%
Catalog No. T0755Alias Ureidoglutaric acid, N-Carbamyl-L-glutamic acid, N-Carbamylglutamate, Carbamylglutamic acid, Carbamino-L-glutamic acid, CarbagluCas No. 1188-38-1

Carglumic Acid (Ureidoglutaric acid) is an orphan drug used to treat hyperammonemia in patients with N-acetyl glutamate synthase absence. This rare hereditary disease results in elevated blood levels of ammonia, which can eventually cross the blood-brain barrier and lead to neurologic problems, coma, cerebral edema, and death. Carglumic acid was approved by the U.S. FDA on 18 March 2010.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
200 mg$48In Stock
500 mg$89In Stock
1 g$119In Stock
1 mL x 10 mM (in DMSO)$55In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Carglumic Acid"

Product Introduction

Bioactivity
Description
Carglumic Acid (Ureidoglutaric acid) is an orphan drug used to treat hyperammonemia in patients with N-acetyl glutamate synthase absence. This rare hereditary disease results in elevated blood levels of ammonia, which can eventually cross the blood-brain barrier and lead to neurologic problems, coma, cerebral edema, and death. Carglumic acid was approved by the U.S. FDA on 18 March 2010.
AliasUreidoglutaric acid, N-Carbamyl-L-glutamic acid, N-Carbamylglutamate, Carbamylglutamic acid, Carbamino-L-glutamic acid, Carbaglu
Chemical Properties
Molecular Weight190.15
FormulaC6H10N2O5
Cas No.1188-38-1
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 45 mg/mL (236.66 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM5.2590 mL26.2950 mL52.5901 mL262.9503 mL
5 mM1.0518 mL5.2590 mL10.5180 mL52.5901 mL
10 mM0.5259 mL2.6295 mL5.2590 mL26.2950 mL
20 mM0.2630 mL1.3148 mL2.6295 mL13.1475 mL
50 mM0.1052 mL0.5259 mL1.0518 mL5.2590 mL
100 mM0.0526 mL0.2630 mL0.5259 mL2.6295 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Carglumic Acid | purchase Carglumic Acid | Carglumic Acid cost | order Carglumic Acid | Carglumic Acid chemical structure | Carglumic Acid formula | Carglumic Acid molecular weight